Changes in the gut microbiome before rheumatoid arthritis is developed could provide a window of opportunity for preventative treatments, new research suggests.
Novartis CEO: Trying to crack obesity market with another first-gen agent is ‘not a prudent approach’
Novartis doesn’t want to play the me-too game in obesity. On Thursday, CEO Vas Narasimhan said that trying to compete in the multibillion-dollar obesity market